1. Introduction
===============

Saeng Maek San (SMS), a traditional Korean herbal medicine, composed of *Panax ginseng, Ophiopogon japonicas*, and *Schisandra chinensis*. In the theory of traditional Chinese medicine (TCM), it strongly supports energy levels that have been severely tapped. This means the qi and the yin have been compromised, leading to signs of thirst and fatigue that contribute to weakness of the body. Furthermore, it has been used to treat symptoms related to cardiovascular diseases such as heart failure, stroke and shock \[[@B001], [@B002]\]. Previous studies have suggested that SMS exerts protective effects against oxidative damage in the cells or tissues of the cardiovascular system and the nervous system \[[@B003] - [@B005]\]. Additionally, earlier studies have shown the preventive effect of SMS against cerebral oxidative damage in rats \[[@B006]\], and Wu *et al* \[[@B007]\]. reported the memory-enhancing potential of SMS in a vascular dementia model.

In an *invitro* model, SMS was reported to protect against amyloid-b-induced cytotoxicity in PC12 cells \[[@B008]\]. Xuejiang *et al*. \[[@B009]\] described the potential of SMS for neuroprotection and neurite outgrowth, which further implicated the applicability of SMS for the treatment of axon-degenerative diseases such as amyotrophic lateral sclerosis (ALS), in which a deficiency of superoxide dismutase (SOD) is thought to be linked to neuronal damage. Also, several studies have established that ginsenoside Rb1, Rg1, schizandrin, and ruscogenin from Sheng-mai San have neuroprotective effects because of their antioxidant, antiapoptosis, and anti-inflammatory actions \[[@B010] - [@B014]\]. DT-13, a saponin with ruscogenin as the parent nucleus, also showed significant anti-inflammatory activity with low toxicity \[[@B015], [@B016]\]. More recently, Guo *et al*. \[[@B017]\] suggested that SMS could regulate the neuronal autophagy and its related AMPK/mTOR and JNK pathways in a MCAO model in mice.

Despite the efficacy and the non-toxicity of SMS, there has to date been no detailed investigation of the acute toxicity of such a commonly used drug. To build upon the above-mentioned studies, the safe concentration of SMS in the blood should be determined. This study provides data regarding both the median lethal dosage (LD~50~) of SMS in rats through different routes of injection and the largest safe dose for intravenous injection.

2. Materials and Methods
========================

SMS, which is a mixture of three traditional herbs, was prepared under sterile conditions at the Korean Pharmacopuncture Institute (K-GMP). The ratio of the herbal drugs in SMS is 2 : 1 : 1 of Liriopis Tuber, Ginseng Radix and Schisandrae Fructus, respectively (total: 5500 g). SMS extract was prepared by decocting the dried prescription in distilled water. The extract was obtained by decocting for approximately 2 hours (total extracts: 12 L), and the pH was controlled to between 7.0 - 7.5 by adding NaOH to make a 0.9% isotonic solution. The final solution was stored at 4°C.

This study used 5-week-old male and female Sprague-Dawley rats (supplied by Orient Bio Inc., Korea) weighing 103.4 - 134.1 g. Sprague-Dawley rats are used widely for drug-safety testing. The animals' weights at the time of injection were 180.4 - 202.2 g and 135.4 - 165.7 g for the male and the female rats, respectively. The general condition of, and any symptoms displayed by, the rats were observed once per day for 7 days following injection; the weights of the rats on day 7 were recorded. The room in which the rats were kept was maintained at 20.0 - 22.8°C, with a relative humidity of 48.5% to 65.9%, natural illumination, and automated ventilation. The animals were housed individually in cages and allowed free access to solid feed (Teklad Certified Irradiated Global 18% Protein Rodent Diet 2918C) and UV-filtered water. Groupings of the rats were allocated 7 days after injection. Animals with weights close to the mean were selected. In total, 20 male and 20 female rats were selected. The animals were randomly distributed into four groups of five rats each (Table [1](#T001){ref-type="table"}).

###### Groups of animals

  ---------------------------------------------------------------------------------------------
  Group                 SMS injection\   Number of animals (serial numbers)   
                        (mL/animal)                                           
  --------------------- ---------------- ------------------------------------ -----------------
  G1: control group     0                5 (1101 - 1105)                      5 (2101 - 2105)

  G2: low-dose group    0.1              5 (1201 - 1205)                      5 (2201 - 2205)

  G3: mid-dose group    0.5              5 (1301 - 1305)                      5 (2301 - 2305)

  G4: high-dose group   1.0              5 (1401 - 1405)                      5 (2401 - 2405)
  ---------------------------------------------------------------------------------------------

In clinical applications, the standard dose for SMS is 1.0 mL per treatment. In our study, 1.0 mL/animal was set as the high dose and 0.5 and 0.1 mL as the medium and the low doses, respectively. Normal saline (1.0 mL) was administered to control rats. A single dose of SMS at the prescribed level was injected intravenously into the rats in the low-, the medium-, and the high-dose experimental groups. Clean disposable syringes were used throughout the study. The study was conducted with the approval of the Institutional Animal Ethics Committee (No.120877).

General symptoms were recorded daily at 1 to 14 days following injection. On the day of dosing (Day 0), general symptoms (side effects, revealing time, recovery time, etc.) and mortality were examined at 30 minutes and at 1, 2, 3 and 4 hours after injection. The weight of each rat was measured immediately before injection and at 3, 7, and 14 days thereafter.

Fifteen days after injection on the day of necropsy, after the rats had been fasted for at least 18 hours, they were anesthetized with isoflurane, and a blood sample was taken from the abdominal aorta). Blood (1.0 mL) was analyzed using an automatic hematology analyzer (ADVIA 120, SIEMEMS, Germany). Blood coagulation was assessed by centrifuging a 2.0-mL blood sample (3,000 rpm, 10 minutes) and taking measurements using an Automated Coagulation Analyzer (Coapresta 2000, SEKISUI, Japan). Biochemical tests were performed on blood taken from the abdominal aorta by using an Automatic Analyzer (7180, HITACHI, Japan) and Electrolyte Analyzer (AVL9181, Roche, Germany).

After completion of the above measurements, all organs and tissues of each rat were inspected visually and were examined under an optical microscope. The organs of each rat were fixed with 10% formalin or Calci-Clear-Rapid^TM^ solution (the latter only for testes showing osseous tissue demineralization), stained with hematoxylin--eosin (H&E) and fixed in paraffin wax. A complete histopathological examination was performed on these tissue samples.

The weight, hematological, and blood biochemical test results were analyzed using the statistical analysis system (SAS) software (versions 9.2 and 9.3, SAS Institute Inc., USA). A Bartlett's test was conducted to evaluate the homogeneity of the variance and significance. A oneway analysis of variance (ANOVA) was conducted when homogeneity of the variance was recognized, and the Kruskal-Wallis test was conducted as a post-hoc analysis.

3\. Results

No deaths or abnormalities occurred in any of the groups, indicating that the LD~50~ of the SMS administered via intravenous injection was greater than 1.0 mL/animal in rats (Table [2](#T002){ref-type="table"}, [3](#T003){ref-type="table"}). In addition, no changes in weight were observed (Table [4](#T004){ref-type="table"}). In this study, even though computation of the LD~50~ was difficult, all groups presented a sustained increase in body weight, but the differences among the groups were not significant. Finally, no significant changes in the hematological results, blood biochemical parameters or necropsy findings were noted (data not shown). Upon histopathological examination, interstitial- infiltrating macrophages were found in one female rat in the 0.5-mL/animal group. No significant changes in the brain, lungs, liver, kidney or spinal cord were found in any of the other groups (Fig [1](#F001){ref-type="fig"}).

###### Mortalities. A single intravenous injection dose of SMS at the each groups including 1.0 mL/animal group caused no mortalities.

  -------------------------------------------------------
  Group   Dose\         Mortality (dead/tested)   
          (mL/animal)                             
  ------- ------------- ------------------------- -------
  G1      0             0%\                       0%\
                        (0/5)\*                   (0/5)

  G2      0.1           0%\                       0%\
                        (0/5)                     (0/5)

  G3      0.5           0%\                       0%\
                        (0/5)                     (0/5)

  G4      1             0%\                       0%\
                        (0/5)                     (0/5)
  -------------------------------------------------------

\*Number of dead animals/number of tested animals

###### Clinical signs. No abnormal clinical symptoms, such as type of toxicity symptom, time of expression, time of recovery were observed after injection.

  -----------------------------------------------------
  Group    Dose\   Sex    Number of\   Clinical signs
                          animals      
  -------- ------- ------ ------------ ----------------
  G1       0       Male   5            NOA

  Female   5       NOA                 

  G2       0.1     Male   5            NOA

  Female   5       NOA                 

  G3       0.5     Male   5            NOA

  Female   5       NOA                 

  G4       1       Male   5            NOA

  Female   5       NOA                 
  -----------------------------------------------------

###### Body weights (g)

  Group    Dose          Sex            Days after administration   Gain                                         
  -------- ------------- -------------- --------------------------- -------------- -------------- -------------- --------------
  G1       0             Male           191 ± 4.3                   216.5 ± 5.2    253.1 ± 6.7    307.6 ± 6.8    116.5 ± 6.9
  Female   151.7 ± 5.3   162.7 ± 3.8    176 ± 4.8                   199.3 ± 5.7    47.6 ± 7.1                    
  G2       0.1           Male           189.7 ± 4.7                 215.8 ± 8.7    252.6 ± 9.8    311.5 ± 14.1   121.9 ± 11.2
  Female   150.8 ± 9.7   162.2 ± 9.8    172.4 ± 11.7                189.9 ± 19.8   39 ± 14.9                     
  G3       0.5           Male           189.3 ± 7.7                 215.5 ± 12     252 ± 13.1     310.1 ± 20.1   120.7 ± 14.6
  Female   152.6 ± 11    163.7 ± 13.7   176.3 ± 13.5                199.9 ± 16.5   47.3 ± 6.6                    
  G4       1             Male           191.8 ± 7.9                 191.8 ± 7.9    257.2 ± 14.2   310 ± 23.4     118.1 ± 17.9
  Female   151 ± 10.1    163.3 ± 9.8    177.5 ± 13.2                199.1 ± 16.8   48.2 ± 10.7                   

![Histopathological observations. H&E, × 200, × 40](2093-6966-v17-n02-067-g001){#F001}

4. Discussion
=============

SMS is a traditional medical formula composed of *Panax ginseng, Ophiopogon japonicas,* and *Schisandra chinensis* and has been used for almost 1,000 years in China. It was first recorded in ''Yixue Qiyuan'', which was written by Zhang Yuansu, a famous physician, during the Jin Dynasty. In China, it has long been used for the treatment of Qi and Yin deficiency and in modern times to treat diverse conditions, including cardiovascular and neurological disorders \[[@B003], [@B005]\]. Previous experimental data have indicated the efficacy of SMS in treating various conditions \[[@B005], [@B018]\]. SMS is used in the treatment of myocardial infarction, where it has a protective effect against the accompanying renal ischemic damage \[[@B019], [@B020]\]. Some studies have reported that SMS can improve sperm viability and movement parameters in vitro \[[@B021]\]. Ginseng has been reported to be effective for tolerable toxicity in the treatment of cancer-related fatigue \[[@B022]\]. Ginseng polysaccharides also displayed anti-fatigue effects in one study in mice \[[@B023]\]. Ginsenosides, the primary active components of ginseng, have been found to have anti-inflammatory and anti-oxidative effects. Neuroprotective effects of ginsenosides were also reported in an AD mouse model \[[@B024]\]. Ginsenoside Rg5 (Rg5) has been suggested as a novel therapeutic agent for treating memory loss \[[@B025]\]. Ophiopogon japonicas is used for Yin deficiency according to TCM theory and has displayed potential for treating hypoglycemia and hypolipidemia in type-2 diabetes \[[@B026]\]. Schisandra chinensis is used to benefit Qi energy and promote body-fluid production according to TCM theory and has been reported to have positive effects in viral- and chemical-induced hepatitis \[[@B027], [@B028]\].

Thus, SMS and its component herbs have been reported to have a myriad of positive effects on several disorders. Although it is used widely in clinics, studies on the safety of SMS are lacking, so further research is needed, and toxicity testing is essential for evaluating the safety of medications \[[@B029]\]. This study was performed to provide objective safety data for SMS. Three SMS doses (0.1, 0.5 and 1.0 mL) were administered to the experimental groups, and 1.0 ml of saline was administered to the control group. In all four groups, no deaths occurred, indicating that the LD~50~ of SMS is greater than 1.0 mL/animal in rats. There were no significant differences between the control group and the experimental groups in the clinical signs, weights, hematologic examination results, and blood biochemical parameters. At necropsy, only one rat displayed any significant histopathological abnormalities in the organs and tissues.

Further studies of the acute and the chronic side effects and the reaction capacity are required to rigorously assess the toxicity of SMS. Animal testing is the most important method of performing these safety assessments \[[@B030]\]. The Korea Food and Drug Administration has testing-protocol guidelines for the assessment of toxicity, and all experiments should be conducted following Good Laboratory Practice (GLP) regulations \[[@B031]\]. In this study, the LD~50~ of SMS in rats was shown to be \> 1.0 mL/animal, indicating that this dose is safe in humans and does not cause significant histological abnormalities. Further studies are needed to yield more data to support our findings.

5. Conclusion
=============

In our study, the administration of 1.0 mL/animal SMS did not produce any significant changes in body weight, in the results of hematological, blood biochemistry or necropsy examinations, or in the incidence of mortality. Our findings indicate that SMS administration up to this dose is a safe option for treatment.
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